Cargando…

Association between lipid variability and the risk of mortality in cancer patients not receiving lipid-lowering agents

AIM: We investigated the association between total cholesterol (TC), low-density lipoprotein (LDL) cholesterol, high-density lipoprotein (HDL) cholesterol, and triglyceride (TG) variability and cancer patient mortality risk. METHODS: We retrospectively analyzed 42,539 cancer patients who were not re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Seohyun, Kim, Gyuri, Cho, So Hyun, Oh, Rosa, Kim, Ji Yoon, Lee, You-Bin, Jin, Sang-Man, Hur, Kyu Yeon, Kim, Jae Hyeon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10586791/ https://www.ncbi.nlm.nih.gov/pubmed/37869078 http://dx.doi.org/10.3389/fonc.2023.1254339

Ejemplares similares

Impact of continuous glucose monitoring on glycemic control and its derived metrics in type 1 diabetes: a longitudinal study
por: Cho, So Hyun, et al.
Publicado: (2023)

Mean and Variability of Lipid Measurements and Risk for Development of Subclinical Left Ventricular Diastolic Dysfunction
por: Park, Jiyun, et al.
Publicado: (2022)

Glycated albumin and its variability as an indicator of cardiovascular autonomic neuropathy development in type 2 diabetic patients
por: Jun, Ji Eun, et al.
Publicado: (2017)

Mean and visit‐to‐visit variability of glycated hemoglobin, and the risk of non‐alcoholic fatty liver disease
por: Yoo, Jee Hee, et al.
Publicado: (2020)

Additive interaction of diabetes mellitus and chronic kidney disease in cancer patient mortality risk
por: Kim, Seohyun, et al.
Publicado: (2022)

Low Household Income Status and Death from Pneumonia in People with Type 2 Diabetes Mellitus: A Nationwide Study
por: Lee, You-Bin, et al.
Publicado: (2023)

Successful Treatment of Xanthoma Disseminatum with Combined Lipid Lowering Agents
por: Kim, Won-Jeong, et al.
Publicado: (2012)

The association of hepatic steatosis and fibrosis with heart failure and mortality
por: Park, Jiyun, et al.
Publicado: (2021)

MAFLD and NAFLD in the prediction of incident chronic kidney disease
por: Kwon, So Yoon, et al.
Publicado: (2023)

Increased risk of incident diabetes in patients with MAFLD not meeting the criteria for NAFLD
por: Park, So Hee, et al.
Publicado: (2023)

Chain flexibility of medicinal lipids determines their selective partitioning into lipid droplets
por: Son, So-Hee, et al.
Publicado: (2022)

CD1-mediated immune responses in mucosal tissues: molecular mechanisms underlying lipid antigen presentation system
por: Kim, Seohyun, et al.
Publicado: (2023)

Judicious Use of Lipid Lowering Agents in the Management of NAFLD
por: Iqbal, Umair, et al.
Publicado: (2018)

Association between cholesterol levels and dementia risk according to the presence of diabetes and statin use: a nationwide cohort study
por: Lee, You-Bin, et al.
Publicado: (2022)

Risk of early mortality and cardiovascular disease according to the presence of recently diagnosed diabetes and requirement for insulin treatment: A nationwide study
por: Lee, You‐Bin, et al.
Publicado: (2021)

Urinary Free Metanephrines for Diagnosis of Pheochromocytoma and Paraganglioma
por: Ahn, Jiyeon, et al.
Publicado: (2021)

Novel Uses for Lipid-Lowering Agents
por: May, Megan Brafford, et al.
Publicado: (2016)

The association between serum lipid profile and the prostate cancer risk and aggressiveness
por: Suh, Jungyo, et al.
Publicado: (2023)

New, Novel Lipid-Lowering Agents for Reducing Cardiovascular Risk: Beyond Statins
por: Kim, Kyuho, et al.
Publicado: (2022)

New, Novel Lipid-Lowering Agents for Reducing Cardiovascular Risk: Beyond Statins
por: Kim, Kyuho, et al.
Publicado: (2022)

Erratum to: An information and communication technology-based centralized clinical trial to determine the efficacy and safety of insulin dose adjustment education based on a smartphone personal health record application: a randomized controlled trial
por: Kim, Gyuri, et al.
Publicado: (2017)

An information and communication technology-based centralized clinical trial to determine the efficacy and safety of insulin dose adjustment education based on a smartphone personal health record application: a randomized controlled trial
por: Kim, Gyuri, et al.
Publicado: (2017)

Regression of asymptomatic intracranial arterial stenosis by aggressive medical management with a lipid-lowering agent
por: Kim, Bo Seok, et al.
Publicado: (2019)

Statins Lower Lipid Synthesis But Promote Secretion of Cholesterol-Enriched Extracellular Vesicles and Particles
por: Chen, Yundi, et al.
Publicado: (2022)

Lipids, lipid-lowering agents, and inflammatory bowel disease: a Mendelian randomization study
por: Tao, Heqing, et al.
Publicado: (2023)

Pharmacogenomics Variability of Lipid-Lowering Therapies in Familial Hypercholesterolemia
por: Hindi, Nagham N., et al.
Publicado: (2021)

Role of lipid-lowering agents in the management of diabetic retinopathy
por: Ioannidou, Estelle, et al.
Publicado: (2017)

Formulation and Evaluation of Nanocrystals of a Lipid Lowering Agent
por: Louis, Dina
Publicado: (2016)

Statins and the Brain: More than Lipid Lowering Agents?
por: Fracassi, Anna, et al.
Publicado: (2019)

The association between glycemic variability and diabetic cardiovascular autonomic neuropathy in patients with type 2 diabetes
por: Jun, Ji Eun, et al.
Publicado: (2015)

Persistence With Lipid-Lowering Therapy: Influence of the Type of Lipid-Lowering Agent and Drug Benefit Plan Option in Elderly Patients
por: Abughosh, Susan M., et al.
Publicado: (2004)

Increase in relative skeletal muscle mass over time and its inverse association with metabolic syndrome development: a 7-year retrospective cohort study
por: Kim, Gyuri, et al.
Publicado: (2018)

Effects of low skeletal muscle mass and sarcopenic obesity on albuminuria: a 7-year longitudinal study
por: Yoo, Jee Hee, et al.
Publicado: (2020)

The associations of hepatic steatosis and fibrosis using fatty liver index and BARD score with cardiovascular outcomes and mortality in patients with new-onset type 2 diabetes: a nationwide cohort study
por: Park, Jiyun, et al.
Publicado: (2022)

Insulin Fact Sheet in Type 1 and 2 Diabetes Mellitus and Trends of Antidiabetic Medication Use in Insulin Users with Type 2 Diabetes Mellitus: 2002 to 2019
por: Park, Jiyun, et al.
Publicado: (2023)

Ginsenoside Rg3 Reduces Lipid Accumulation with AMP-Activated Protein Kinase (AMPK) Activation in HepG2 Cells
por: Lee, Seohyun, et al.
Publicado: (2012)

GENetic characteristics and REsponse to lipid-lowering therapy in familial hypercholesterolemia: GENRE-FH study
por: Kim, Hyoeun, et al.
Publicado: (2020)

Proper adjuvant therapy in patients with borderline resectable and locally advanced pancreatic cancer who had received neoadjuvant FOLFIRINOX
por: Choi, Jin Ho, et al.
Publicado: (2022)

Association of Urinary N-Acetyl-β-D-Glucosaminidase with Cardiovascular Autonomic Neuropathy in Type 1 Diabetes Mellitus without Nephropathy
por: Choi, Min Sun, et al.
Publicado: (2021)

Garlic as a Lipid Lowering Agent—A Meta-Analysis
por: Silagy, Christopher, et al.
Publicado: (1994)

Cannot write session to /tmp/vufind_sessions/sess_e9blioc0cr1r2t5adl2tope4jp